Compared to Estimates, Equity Bancshares (EQBK) Q4 Earnings: A Look at Key Metrics

Zacks Zacks
Compared to Estimates, Equity Bancshares (EQBK) Q4 Earnings: A Look at Key Metrics

Equity Bancshares (EQBK) reported $73.03 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 25.3%. EPS of $1.26 for the same period compares to $1.10 a year ago.

The reported revenue represents a surprise of +1.79% over the Zacks Consensus Estimate of $71.75 million. With the consensus EPS estimate being $1.22, the EPS surprise was +3.56%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Equity Bancshares performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Interest Margin: 4.5% versus 4.4% estimated by two analysts on average. Efficiency ratio: 60% versus 59.7% estimated by two analysts on average. Total Non-Interest Income: $9.53 million versus $9.05 million estimated by two analysts on average. Net Interest Income: $63.5 million versus the two-analyst average estimate of $62.7 million.

View all Key Company Metrics for Equity Bancshares here>>>

Shares of Equity Bancshares have returned +2.4% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Equity Bancshares, Inc. (EQBK): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

其他新闻